Jazz Pharmaceuticals plc (JAZZ)

NASDAQ: JAZZ · IEX Real-Time Price · USD

105.25

-0.21 (-0.20%)

At close: May 31, 2024, 4:00 PM

105.15

-0.10 (-0.10%)

After-hours: May 31, 2024, 6:56 PM EDT

Jazz Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2004
Revenue	3,834	3,659	3,094	2,364	2,162	Upgrade
Revenue Growth (YoY)	4.78%	18.26%	30.91%	9.34%	14.32%	Upgrade
Cost of Revenue	435.58	540.52	440.76	148.92	127.93	Upgrade
Gross Profit	3,399	3,119	2,653	2,215	2,034	Upgrade
Selling, General & Admin	1,343	1,417	1,452	854.23	736.94	Upgrade
Research & Development	849.66	590.45	505.75	335.38	299.73	Upgrade
Other Operating Expenses	627.28	1,177	525.77	646.97	464.79	Upgrade
Operating Expenses	2,820	3,184	2,483	1,837	1,501	Upgrade
Operating Income	578.58	-65.53	170.28	378.07	532.37	Upgrade
Interest Expense / Income	289.44	288.24	278.77	99.71	72.26	Upgrade
Other Expense / Income	-5.78	28.94	5.06	6.23	9.9	Upgrade
Pretax Income	294.92	-382.71	-113.55	272.13	450.21	Upgrade
Income Tax	-119.91	-158.65	216.12	33.52	-73.15	Upgrade
Net Income	414.83	-224.06	-329.67	238.62	523.37	Upgrade
Net Income Growth	-	-	-	-54.41%	17.06%	Upgrade
Shares Outstanding (Basic)	63	63	60	56	57	Upgrade
Shares Outstanding (Diluted)	72	63	60	57	58	Upgrade
Shares Change	15.23%	4.77%	5.62%	-1.79%	-6.00%	Upgrade
EPS (Basic)	6.55	-3.58	-5.52	4.28	9.22	Upgrade
EPS (Diluted)	6.10	-3.58	-5.52	4.22	9.09	Upgrade
EPS Growth	-	-	-	-53.58%	24.52%	Upgrade
Free Cash Flow	1,068	1,243	750.87	884.64	750.48	Upgrade
Free Cash Flow Per Share	16.88	19.87	12.58	15.88	13.22	Upgrade
Gross Margin	88.64%	85.23%	85.76%	93.70%	94.08%	Upgrade
Operating Margin	15.09%	-1.79%	5.50%	16.00%	24.63%	Upgrade
Profit Margin	10.82%	-6.12%	-10.65%	10.10%	24.21%	Upgrade
Free Cash Flow Margin	27.86%	33.97%	24.27%	37.43%	34.72%	Upgrade
Effective Tax Rate	-40.66%	-	-	12.32%	-16.25%	Upgrade
EBITDA	1,223	535.01	717.7	650.09	892.63	Upgrade
EBITDA Margin	31.90%	14.62%	23.19%	27.50%	41.29%	Upgrade
Depreciation & Amortization	638.7	629.47	552.48	278.25	370.16	Upgrade
EBIT	584.36	-94.46	165.21	371.84	522.47	Upgrade
EBIT Margin	15.24%	-2.58%	5.34%	15.73%	24.17%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).